Background
==========

Human papilloma virus (HPV) is one of the most commonly diagnosed STIs, with over 630 million HPV infections worldwide and an overall prevalence between 9-13% \[[@B1]\]. A systematic review documented that the prevalence of HPV infection varies among men \[[@B2]\]. However, these wide estimates have been attributed to different sampling methods \[[@B2],[@B3]\], as well as to differences in the populations studied \[[@B3]\]. Regarding HPV-related cancers, worldwide studies have reported presence of HPV infection for oropharyngeal \[[@B4]\], anal \[[@B5]\] and penile cancers \[[@B6]\]. Despite the reported global burden of HPV infection and HPV-related cancers in men \[[@B7]\], few studies have evaluated HPV and HPV-related cancer knowledge \[[@B8],[@B9]\] particularly among high-risk men.

Although knowledge is not a direct predictor of health behavior \[[@B10]\], it is mediated by attitudes, risk perceptions, social influence and self-efficacy \[[@B11]\]. Thus, acquiring knowledge is a key first step to the success of any health education intervention. Although there has been increased attention to HPV awareness and knowledge in the literature \[[@B12],[@B13]\], most of the available research has focused on women \[[@B11],[@B14],[@B15]\]. Studies in men, particularly among those of Hispanic origin, are scarce. Among the few studies that have evaluated gender differences, men have lower knowledge about HPV compared to women \[[@B16],[@B17]\].

In Puerto Rico (PR), despite the HIV epidemic and documented high-risk sexual practices in population-based studies \[[@B18],[@B19]\], there is limited epidemiological and behavioral research on knowledge of HPV infection, particularly among high-risk groups; this may delay the development of effective interventions to reduce the burden of HPV infection. This kind of research is necessary, given that epidemiological evidence indicates that men in PR, particularly HIV+ men, have higher rates of HPV-related cancers compared to the general population of PR \[[@B20]\]. Therefore, in order to understand the determinants of knowledge of HPV infection, it is necessary to evaluate high-risk groups, particularly individuals whose average rate of acquisition of new sexual partners is sufficiently high to maintain increasing numbers of secondary infections. STI clinics can be an ideal setting for reaching these high-risk groups \[[@B21]\]. Studies in STI clinics have reported high prevalence estimates of HPV infection; but knowledge in patients from these settings is limited \[[@B22]-[@B24]\]. This study aims to describe the proportion of men that attend an STI clinic in PR who are aware of HPV, determine their level of knowledge about HPV infection, and identify correlates of HPV knowledge within this group.

Methods
=======

This study was part of an ongoing epidemiological core study among men and women attending the Latin American Center for Sexually Transmitted Diseases (CLETS, by its initials in Spanish), located in San Juan, Puerto Rico A full description of the methodology used in the core study has been described elsewhere \[[@B25]\]. Briefly, it involved recruitment of men and women from the clinic waiting, coupled with subsequent screening to confirm eligibility (at least 16 years of age) and capacity for informed consent. Study participation was voluntary and written informed consent was obtained. Study subjects participated in a structured behavioral interview that was administered by the research staff and data were recorded utilizing QDS software \[[@B26]\]. Domains in the survey included demographic characteristics (age, education, income, employment status, and marital status); number of female sexual partners (last 90 days), sexual identity (Men who have Sex with Men (MSM), non-MSM), consumption of alcohol, tobacco or illegal substances (last 90 days); sexual history and self-reported history of STIs; and current sexual risk profile (last 90 days).

Following completion of the core survey interview, all male participants were informed of the opportunity to participate in an additional interview as part of an HPV study. Men expressing interest in the HPV study were required to provide additional written informed consent for a second interview, which included questions regarding HPV awareness, HPV knowledge, perceived susceptibility to HPV-related cancers, HPV vaccine awareness, and willingness to be vaccinated against HPV.

Data collection procedures were approved by the University of Puerto Rico, Medical Sciences Campus Institutional Review Board (UPR-IRB).

HPV knowledge
-------------

Based on both existing measures \[[@B27]\] and additional input from the study team, a 21-item scale measure was used to address HPV knowledge. Response options included true, false and don't know. An incorrect or *'don't know'* answer was given a score of 0. An example of items included in this scale was '*only women can get infected with HPV*'. Latter sets of questions were assessed only among those who reported having heard of HPV infection before the survey (n=106), or 52.5% of the total sample.

Statistical analysis
--------------------

Exploratory factor analysis of the 21 item scale measuring HPV knowledge identified 4 subscales, in which one factor (15 item scale) was related to HPV knowledge. Chrombach alpha for the 15 item scale was 0.75.

A mean knowledge score was computed by summing correct responses of the 15 item scale, with higher scores meaning a higher knowledge. Adequate knowledge was defined as a minimum score of 70% \[[@B28]\]. Chi-square tests were used to identify relationships between demographic and behavioral characteristics, and self-reported STIs with adequate HPV knowledge. Variables that achieved statistical significance (p \< 0.05) were assessed in the logistic regression models. Due to the reported association between age and HPV knowledge in the literature \[[@B29]\], Model 1 was adjusted for age. Then, a multivariate logistic regression model was performed (Model 2) to determine predictors of adequate HPV knowledge after controlling by all the independent variables in the model. All statistical analyses were performed using the statistical package SAS (Version 9.1,Cary,NC).

Results
=======

Participants' characteristics
-----------------------------

A total of 206 men participated in the study, of which 202 (98.1%) completed the full assessment (behavioral interview and HPV supplement). Demographic and individual HPV risk-related characteristics are shown in Table [1](#T1){ref-type="table"}. The mean age of the study participants was 37.8 years (SD=13.12). Over half (54.4%) had less than high school education; 61.9% were employed at the time of the interview. Nearly 20% were without medical insurance (neither private nor government-sponsored plan).

###### 

Factors associated with adequate HPV knowledge among men aware of HPV, attending an STI clinic in Puerto Rico

  **Variables**                                                 **Adequate HPV Knowledge**^**\***^**(n=106)**                
  ---------------------------------------------- ------------- ----------------------------------------------- ------------- -------------
  **Sociodemographic characteristics**                                                                                       
  **Age (years)**                                    0.969                                                                   
    Mean ± SD                                     37.8 ± 13.1                    36.6 ± 13.2                    41.3 ± 17.4         
  **Educational Level**                              0.607                                                                   
    \< High School                                 36 (17.8)                      9 (12.0)                        3 (9.7)           
    High School                                    74 (36.6)                      28 (37.3)                      9 (29.0)           
    \> High School                                 92 (45.5)                      38 (50.7)                      19 (61.3)          
  **Employment**                                     0.915                                                                   
    No                                             77 (38.1)                      21 (28.0)                      9 (29.0)           
    Yes                                           125 (61.9)                      54 (72.0)                      22 (71.0)          
  **Individual Annual Income**                       0.572                                                                   
    None                                           57 (28.2)                      16 (21.3)                      5 (16.1)           
    \< \$15,000                                   104 (51.5)                      40 (53.3)                      20 (64.5)          
    ≥ \$15,000                                     41 (20.3)                      19 (25.3)                      6 (19.4)           
  **Health Insurance**                               0.788                                                                   
    None                                           37 (18.3)                      13 (18.1)                      4 (13.8)           
    Public                                        119 (58.9)                      16 (22.2)                      8 (27.6)           
    Private                                        39 (19.3)                      43 (59.7)                      17 (58.6)          
  **Behavioral Factors**                                                                                                     
  **Tobacco Use (last 90 days)**                                                                                                 0.253
    No                                             96 (47.5)                      32 (42.7)                      17 (54.8)          
    Yes                                           106 (52.5)                      43 (57.3)                      14 (45.2)          
  **Alcohol Use (last 90 days)**                     0.812                                                                   
    No                                             82 (40.6)                      26 (34.7)                      10 (32.3)          
    Yes                                           120 (59.4)                      49 (65.3)                      21 (67.7)          
  **Drug Use (last 90 days)**                        0.132                                                                   
    No                                             128(63.4)                      44 (58.7)                      23 (74.2)          
    Yes                                            74(36.6)                       31 (41.3)                      8 (25.8)           
  **Female Sexual Partners (last 90 days)**          0.589                                                                   
    None                                          100 (49.5)                      37 (49.3)                      17 (54.8)          
    1 partner                                      77 (38.1)                      28 (37.3)                      12 (38.7)          
    \> 1 partner                                   25 (12.4)                      10 (13.3)                       2 (6.5)           
  **Sexual Identity**                                0.028                                                                          
    Non-MSM                                       142 (70.3)                      51 (68.0)                      14 (45.2)          
    MSM                                            59 (29.2)                      24 (32.0)                      17 (54.8)          
  **Lifetime history of STIs (self-reported)**                                                                               
  **Herpes**                                                                                                                  0.001^\*\*^
    No                                            171 (84.7)                      70 (93.3)                      21 (67.7)          
    Yes                                            30 (14.9)                       5 (6.7)                       10 (32.3)          
  **Gonorrhea**                                      0.120                                                                   
    No                                            170 (84.2)                      65 (86.7)                      23 (74.2)          
    Yes                                            31 (15.3)                      10 (13.3)                      8 (25.8)           
  **HIV**                                            0.913                                                                   
    No                                            118 (58.4)                      42 (56.0)                      17 (54.8)          
    Yes                                            84 (41.6)                      33 (44.0)                      14 (45.2)          
  **Genital Warts**                                  0.009                                                                   
    No                                            156 (77.3)                      58 (77.3)                      16 (51.6)          
    Yes                                            45 (22.3)                      17 (22.7)                      15 (48.4)          
  **Chlamydia**                                   1.000^\*\*^                                                                
    No                                            179 (88.6)                      68 (90.7)                      28 (90.3)          
    Yes                                            21 (10.4)                       7 (9.3)                        3 (9.7)           
  **Syphilis**                                       0.530                                                                   
    No                                            168 (83.2)                      62 (82.7)                      24 (77.4)          
    Yes                                            33 (16.3)                      13 (17.3)                      7 (22.6)           

^\*^Only those that reported having heard about HPV were included in this analysis. Adequate knowledge was defined as a score of at least 70% of the correct responses.

^\*\*^Fisher's exact tests were performed.

Recent tobacco, alcohol and drug use
------------------------------------

More than half reported recent (last 90 days) use of tobacco (52.5%) and alcohol (59.4%). More than a third (36.6%) reported recent illicit drug use.

Sexual behaviors and practices
------------------------------

12.4% of the men interviewed have had more than one sexual partner in the last 3 months. A significant proportion of study participants identified as being men who have sex with men (MSM) (29.2%). Among those reporting vaginal sex, more than a half (56.9%) reported condom use in their last sexual intercourse, and 33.7% of the participants were circumcised (*data not shown*).

HPV knowledge
-------------

More than half (52.5%; n=106) of the sample had heard about HPV infection before the survey. Primary sources of information included television (24%), print media (e.g., magazines, newspapers, etc.) (13%), and health care professionals (10.5%) (*data not shown*). However, only 29.3% of these men demonstrated an adequate level of knowledge of HPV. Table [2](#T2){ref-type="table"} shows the absolute and relative frequencies of correct answers for each item scored regarding HPV knowledge. The proportion of the correct responses ranged from 16.0% to 90.6%. Most knew that HPV is a sexually transmitted infection (85.9%). However, more than half 58.5% were unaware that genital HPV is transmitted through skin-to-skin contact. With respect to knowledge of the long-term consequences of HPV infection, half (50.0%) were aware that HPV can cause penile cancer and just 27.4% knew that HPV infection has a role in oral cancer. Conversely, 38.7% of men were unaware of the link between HPV and anal cancer.

###### 

Absolute and relative frequencies of correct answers for each item scored regarding HPV knowledge (n=106)

  **Item**                                                                                 **Frequency**   **% Correct**
  --------------------------------------------------------------------------------------- --------------- ---------------
  1\. Genital warts are caused by HPV                                                           70             66.04
  2\. HPV is a virus that can cause cervical cancer                                             82             77.36
  3\. I can infect my sexual partner with HPV, even though I don't present the symptoms         86             81.13
  4\. HPV can cause genital warts in the penis                                                  60             56.60
  5\. HPV can cause genital warts in the anus                                                   55             51.89
  6\. HPV can cause penile cancer                                                               53             50.00
  7\. HPV is sexually transmitted                                                               91             85.85
  8\. As more sexual partners I get, more the risk of getting infected with HPV                 96             90.57
  9\. There are many HPV types                                                                  63             59.43
  10\. HPV is associated with oral cancer                                                       29             27.36
  11\. Some HPV types can disappear without treatment                                           32             30.19
  12\. Genital HPV is transmitted through skin by skin contact                                  44             41.51
  13\. Condom use prevents HPV infection^¥^                                                     63             59.43
  14\. All HPV types cause cancer^¥^                                                            47             44.34
  15\. HPV can cause anal cancer                                                                65             61.32

Mean Score ± SD: 8.8 ± 3.5 points.

^¥^Items 13 and 14 were false.

Table [1](#T1){ref-type="table"} shows the association between demographic, behavioral and clinical factors associated with adequate knowledge of HPV. Factors significantly associated with adequate HPV knowledge in bivariate analyses were being MSM (p \< 0.028), having a self-reported history of herpes infection (p \< 0.001), and a self-reported history of genital warts (p \< 0.009).

Table [3](#T3){ref-type="table"} shows the results of the age-adjusted and multivariate logistic regression models evaluating factors associated with adequate HPV knowledge among men.

###### 

Logistic regression models of factors associated to adequate HPV knowledge

                         **Model 1**^**†**^   **Model 2**^**‡**^                      
  --------------------- -------------------- -------------------- ------------------- -------
  **Sexual Identity**                               0.030                              0.070
    Non-MSM                     1.00                                     1.00             
    MSM                   2.59 (1.10-6.11)                         2.34 (0.93-5.88)       
  **Herpes**                                        0.001                              0.016
    No                          1.00                                     1.00             
    Yes                  7.38 (2.17-25.06)                         4.97 (1.34-18.41)      
  **Genital warts**                                 0.010                              0.121
    No                          1.00                                     1.00             
    Yes                   3.22 (1.32-7.85)                         2.19 (0.81-5.91)       

^**†**^**Model 1:** Adjusted by age.

^**‡**^**Model 2:** Adjusted by age, sexual identity, self-reported history of herpes and genital warts.

In the age-adjusted model, men who have identified as MSM were almost three times more likely to have an adequate knowledge of HPV compared to Non-MSM (age-adjusted OR=2.59; 95% CI=1.10-6.11). Men who reported a history of herpes (age-adjusted OR=7.38; 95% CI=2.17-25.06) and genital warts (age-adjusted OR=3.22; 95% CI=1.32-7.85) also were more likely to have adequate knowledge of HPV. In multivariate models (Table [3](#T3){ref-type="table"}), only having a history of herpes infection remained positively associated with adequate HPV knowledge. MSM were up to two times more likely to have an adequate knowledge of HPV compared to non-MSM. However, this association achieved only marginal significance (p \< 0.07).

Discussion
==========

To our knowledge, this is the first study to attempt to examine awareness of HPV infection among men in PR. In a sample in which none of the study participants has being vaccinated and the awareness of the vaccine is low \[[@B30]\], results show that despite acknowledgement by more than half of the sample that they had heard about HPV infection, a low proportion of study participants had adequate knowledge of HPV. It should be pointed out that among those men that were aware of HPV infection, high levels of knowledge regarding the association of HPV infection with cervical cancer and some risk factors (such as number of sexual partners) was reported. It is likely that the higher levels of adequate HPV knowledge among men with a self-reported history of STIs stems from education they received during the course of STI treatment. This suggests that STI service providers are a good source of education and also that HPV knowledge may be retained in this high-risk population, although further research in this area is warranted. Our results indicate that greater attention is needed to educate men about the potential long-term consequences of HPV infection, including increased risk for oral, penile, and anal cancers \[[@B31]\].

Common sources of HPV information that were identified in this study were television, magazine and newspaper, followed by health care professionals and physicians. These sources of information are inconsistent with results from the population-based 2009 HINTS survey in PR, which showed that the Internet is the primary source for cancer information used by the general population of PR \[[@B32]\]. A possible explanation for this discrepancy is that our study sample was recruited in an STI clinic and primarily comes from a low socioeconomic background. Thus, sources of information and health literacy in this group might differ to those from the general population. This needs to be further investigated in order to identify a mechanism for dissemination which will help to increase knowledge about HPV in this high-risk population.

After age-adjusted logistic regression analysis, a marginal association between MSM and adequate knowledge of HPV was observed. Findings from an online survey in the US show similar results \[[@B31]\]. In this study, 22% of MSM reported genital warts; therefore, knowledge of HPV infection might have been the result of their previous infection. Additionally, qualitative studies among MSM in Puerto Rico attending STI clinics have shown that knowledge of HPV-related cancers in this group is limited \[[@B33]\]. Since studies have demonstrated a high prevalence of HPV infection in MSM, along with a high rate of HPV-related anal cancer \[[@B34]\], this group constitutes a unique population that will greatly benefit from the development of health interventions to increase knowledge of HPV and of related morbidities.

Although results from this clinic-based study are of great relevance for the development of cancer prevention and control efforts among men in PR, our findings need to be interpreted with caution. Research in an STI setting has limitations. Primary among these is that our findings might not generalize to the general population. Specificity and complexity of some of the items of our HPV knowledge score also needs to be further explored for future efforts. Despite its potential limitations, data collected from a highly selective population, such as a public STI clinic, may also offer an opportunity to reach targeted high-risk groups more efficiently.

Conclusion
==========

In summary, this study highlights the low prevalence of HPV awareness and of adequate knowledge of HPV infection in a sexually active group of men attending an STI clinic in Puerto Rico. Findings highlight the need to increase HPV awareness, primarily of HPV-related cancers such as oral and anal cancer. STI clinics might serve as venues for cancer prevention and control among high-risk men. In order to effectively moving forward strategies in these settings, further research which will help us understanding levels of health literacy, stratified by groups of interest, needs to be performed.
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